High Growth Tech Stocks in South Korea Featuring Devsisters and Two More

Separated by the Chuseok Thanksgiving holiday, the South Korea stock market has moved higher in three straight sessions, improving more than 65 points or 2.6 percent along the way. The KOSPI now sits just above the 2,580-point plateau and it's tipped to open in the green again on Friday. In this optimistic market environment, identifying high-growth tech stocks like Devsisters can be a strategic move for investors looking to capitalize on upward trends and technological advancements. This article will explore three promising tech stocks in South Korea that are poised to benefit from these favorable conditions.

Top 10 High Growth Tech Companies In South Korea

Name	Revenue Growth	Earnings Growth	Growth Rating
Seojin SystemLtd	33.61%	52.05%	★★★★★★
IMLtd	21.80%	111.43%	★★★★★★
Bioneer	23.53%	97.58%	★★★★★★
FLITTO	32.60%	106.82%	★★★★★★
NEXON Games	29.64%	66.98%	★★★★★★
Park Systems	23.64%	35.66%	★★★★★★
ALTEOGEN	64.22%	99.46%	★★★★★★
Devsisters	29.08%	63.02%	★★★★★★
AmosenseLtd	24.04%	71.97%	★★★★★★
UTI	114.97%	134.59%	★★★★★★

Click here to see the full list of 49 stocks from our KRX High Growth Tech and AI Stocks screener.

We'll examine a selection from our screener results.

Devsisters (KOSDAQ:A194480)

Simply Wall St Growth Rating: ★★★★★★

Overview: Devsisters Corporation develops mobile games in South Korea and internationally, with a market cap of ₩398.95 billion.

Operations: The company generates revenue primarily from its computer graphics segment, amounting to ₩186.57 million. The business focuses on mobile game development for both domestic and international markets.

Devsisters has demonstrated a notable turnaround in its financial performance, with second-quarter sales soaring to KRW 51.82 billion, up from KRW 36.46 billion the previous year, and transforming a net loss into a profit of KRW 6.27 billion. This resurgence is underpinned by an aggressive R&D strategy that not only fuels innovation but also aligns with anticipated revenue growth of 29.1% annually, outpacing the broader South Korean market's growth rate of 10.4%. Moreover, earnings are expected to surge by approximately 63% yearly, highlighting the company's potential in leveraging cutting-edge technology to scale operations efficiently within the competitive tech landscape. Despite current unprofitability in comparison to industry peers, Devsisters' strategic investments in research and development are set to forge a path toward profitability within three years—a prospect further supported by an impressive forecasted return on equity of 29%. The company's focus on expanding its technological capabilities could significantly influence its market standing and future financial health, provided it continues to navigate market volatility effectively and sustain its investment in innovation.

• Click here and access our complete health analysis report to understand the dynamics of Devsisters.

• Examine Devsisters' past performance report to understand how it has performed in the past.

NEXON Games (KOSDAQ:A225570)

Simply Wall St Growth Rating: ★★★★★★

Overview: NEXON Games Co., Ltd. operates as a game developer with a market cap of ₩987.09 billion.

Operations: The company generates revenue primarily from game sales amounting to ₩190.97 billion, supplemented by rental income sales of ₩2.42 million and other sales of ₩520 million.

NEXON Games, a South Korean tech firm, is navigating the competitive landscape with a robust focus on R&D, which is evident from its substantial investment amounting to 67.0% of its revenue. This strategic emphasis not only enhances its product offerings but also solidifies its position in the gaming industry by fostering innovation and technological advancements. Despite facing challenges like high volatility in share prices over the past three months, NEXON's aggressive growth strategy is reflected in its revenue projections, expected to outpace the market with an annual increase of 29.6%. Furthermore, while currently unprofitable, the company's future looks promising with an anticipated profitability within three years and an impressive forecasted return on equity at 26.6%, signaling potential for significant financial improvements driven by continuous investments in research and development.

• Take a closer look at NEXON Games' potential here in our health report.

• Review our historical performance report to gain insights into NEXON Games''s past performance.

Genomictree (KOSDAQ:A228760)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Genomictree Inc. (KOSDAQ:A228760) is a biomarker-based molecular diagnostics company that develops and commercializes products for detecting cancer and infectious diseases, with a market cap of ₩413.21 billion.

Operations: The company generates revenue primarily through its Cancer Molecular Diagnosis Business, which accounts for ₩1.93 billion, and also engages in Genomic Analysis with revenues of ₩109.21 million.

Genomictree, amidst a volatile market, showcases a promising trajectory with its revenue expected to surge by 90.5% annually, outpacing the South Korean market's average of 10.4%. This growth is underpinned by an aggressive R&D strategy, where expenses are not just substantial but pivotal, fostering innovation that could redefine its market standing. Despite current unprofitability and a challenging comparison to the Biotech industry's modest 6.1% earnings growth last year, Genomictree is projected to reverse this trend dramatically with an earnings increase of 107.8% per year. This potential turnaround highlights not only resilience but also an adaptability that could soon position it favorably within high-growth sectors in South Korea.

• Get an in-depth perspective on Genomictree's performance by reading our health report here.

• Evaluate Genomictree's historical performance by accessing our past performance report.

Make It Happen

• Take a closer look at our KRX High Growth Tech and AI Stocks list of 49 companies by clicking here.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com